Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Galmed Pharmaceuticals Ltd. (GLMD) had Earnings per Share (EPS) (Basic) of $-8.08 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-7.52M |
|
-- |
|
-- |
|
$6.28M |
|
$-6.28M |
|
$-1.24M |
|
$-7.52M |
|
$-6.37M |
|
$-7.52M |
|
$-7.52M |
|
$-7.52M |
|
$-6.37M |
|
$-6.28M |
|
$-6.21M |
|
0.93M |
|
0.93M |
|
|
Earnings per Share (EPS) (Basic) |
$-8.08 |
$-8.08 |
|
| Balance Sheet Financials | |
$16.12M |
|
-- |
|
$2.38M |
|
$18.50M |
|
$2.17M |
|
-- |
|
-- |
|
$2.17M |
|
$16.33M |
|
$16.33M |
|
$16.33M |
|
1.67M |
|
| Cash Flow Statement Financials | |
$-5.88M |
|
$-1.11M |
|
$8.79M |
|
$2.98M |
|
$4.77M |
|
$1.79M |
|
$0.53M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.42 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.88M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-46.04% |
|
-46.04% |
|
-40.63% |
|
-46.04% |
|
$9.81 |
|
$-6.32 |
|
$-6.32 |
|